Company Profile Sector: Health Care Industry: Biotechnology Company Location: Cranbury, NJ Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of...
PTN NEXT MOVE. BUY THE DEEP, DONT GO CRAZY & HOLD FOR 1 TO 3 WEEKS OR 20 TO 50 %
Breakout, retest, potential triple bottom Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems.
Will Women get an F&DA approval for their VIAGRA?? Good entry with LT target 4-5 if approved. This chart is for own use. Viewers come to own conclusions and appreciate comments and learning thoughts.